Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-001203
Filing Date
2025-04-04
Accepted
2025-04-04 08:39:18
Documents
1
Period of Report
2025-04-04

Document Format Files

Seq Description Document Type Size
1 6-K zk2532975.htm 6-K 13531
  Complete submission text file 0001178913-25-001203.txt   14631
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-22320 | Film No.: 25812154
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)